• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Phosphatidylcholine and peritoneal transport during peritoneal dialysis.

作者信息

Di Paolo N, Buoncristiani U, Capotondo L, Gaggiotti E, De Mia M, Rossi P, Sansoni E, Bernini M

出版信息

Nephron. 1986;44(4):365-70. doi: 10.1159/000184022.

DOI:10.1159/000184022
PMID:3796777
Abstract

Peritoneal effluent of patients on chronic ambulatory peritoneal dialysis (CAPD) contains a surface-active material (SAM) made up of phospholipids and showing phosphatidylcholine on thin-layer chromatography. This substance drastically lowers surface tension, helps to repel water and has a lubricating effect. The presence of stratified phosphatidylcholine on the peritoneum might narrow the stagnant dialysate fluid layer and situations which can alter the quantity or composition of SAM may affect peritoneal transport and also, perhaps, the formation of adherences. This led us to verify, experimentally, the presence of phospholipids in basal conditions, after CAPD and during peritonitis and to check if addition of phosphatidylcholine to dialysis liquid is able to modify water transport in patients with low ultrafiltration and peritonitis. Phospholipids in the dialysis effluent of patients who have been on CAPD for a long time are lower than observed in the first days of peritoneal dialysis. A more drastic, significant decrease in phospholipids was observed in patients with low ultrafiltration and in patients with peritonitis. Mean ultrafiltration significantly increases in patients with low ultrafiltration and in those with peritonitis during dialysis exchanges containing phosphatidylcholine (50 mg/l) indicating that the latter is able to restore normal physiological conditions.

摘要

相似文献

1
Phosphatidylcholine and peritoneal transport during peritoneal dialysis.
Nephron. 1986;44(4):365-70. doi: 10.1159/000184022.
2
Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.在部分伴有或不伴有腹膜炎的患者进行持续性非卧床腹膜透析治疗期间,腹膜水转运的变化。
Perit Dial Int. 2004 Nov-Dec;24(6):571-9.
3
Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.腹膜动力学的纵向变化:腹膜透析和腹膜炎的影响
Nephrol Dial Transplant. 1996 Mar;11(3):498-506.
4
Intraperitoneal phosphatidylcholine levels in patients on continuous ambulatory peritoneal dialysis do not correlate with adequacy of ultrafiltration.持续非卧床腹膜透析患者的腹腔内磷脂酰胆碱水平与超滤充分性无关。
J Am Soc Nephrol. 1993 Jun;3(12):1954-60. doi: 10.1681/ASN.V3121954.
5
Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析期间经腹膜水转运的长期变化
Nephron. 1984;38(4):238-47. doi: 10.1159/000183316.
6
Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD.快速转运状态下的自由水转运:持续性非卧床腹膜透析相关性腹膜炎与长期腹膜透析的比较
Kidney Int. 2004 Jan;65(1):298-303. doi: 10.1111/j.1523-1755.2004.00358.x.
7
Transperitoneal water transport before, during, and after episodes with infectious peritonitis in patients treated with CAPD.持续性非卧床腹膜透析(CAPD)治疗患者发生感染性腹膜炎期间及前后的经腹膜水转运情况。
Am J Kidney Dis. 2004 Mar;43(3):485-91. doi: 10.1053/j.ajkd.2003.10.043.
8
Modification of peritoneal ultrafiltration capacity in children undergoing peritoneal dialysis.
Int J Pediatr Nephrol. 1985 Jan-Mar;6(1):35-40.
9
Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis.持续非卧床腹膜透析(CAPD)五年后的腹膜功能参数:晚期腹膜炎的影响
Perit Dial Int. 1989;9(4):329-32.
10
Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients.
Perit Dial Int. 1992;12(4):359-64.

引用本文的文献

1
Fundamentals of Membrane Lipid Replacement: A Natural Medicine Approach to Repairing Cellular Membranes and Reducing Fatigue, Pain, and Other Symptoms While Restoring Function in Chronic Illnesses and Aging.膜脂质置换基础:一种通过自然医学方法修复细胞膜、减轻疲劳、疼痛及其他症状,同时恢复慢性病和衰老状态下机体功能的方法。
Membranes (Basel). 2021 Nov 29;11(12):944. doi: 10.3390/membranes11120944.
2
Increased storage and secretion of phosphatidylcholines by senescent human peritoneal mesothelial cells.衰老的人腹膜间皮细胞中磷脂酰胆碱的储存和分泌增加。
Clin Exp Nephrol. 2016 Aug;20(4):544-551. doi: 10.1007/s10157-015-1192-1. Epub 2015 Nov 2.
3
Increased expression of surfactant protein A and D in rheumatoid arthritic synovial fluid (RASF).
类风湿性关节炎滑液(RASF)中表面活性蛋白A和D的表达增加。
Croat Med J. 2006 Feb;47(1):155-61.
4
Expression of hydrophilic surfactant proteins by mesentery cells in rat and man.大鼠和人体中肠系膜细胞亲水性表面活性蛋白的表达。
Biochem J. 1997 Nov 15;328 ( Pt 1)(Pt 1):251-6. doi: 10.1042/bj3280251.